Evidence map›Paper›PMID 30455348›Full record

ArticleThe Journal of biological chemistry2019

Glucosamine improves survival in a mouse model of sepsis and attenuates sepsis-induced lung injury and inflammation.

Ji-Sun Hwang, Kyung-Hong Kim, Jiwon Park, Sang-Min Kim, Hyeongjin Cho, Yunkyoung Lee, Inn-Oc Han

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 166 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Glucosamine as a regulator of O-GlcNAc signaling: linking metabolism to disease pathogenesis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  9. Article
  10. Article
  11. Hydrogen gas (HFrontiers in immunology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ji-Sun HwangFrom the Department of Physiology and Biophysics, College of Medicine, and.
Kyung-Hong KimFrom the Department of Physiology and Biophysics, College of Medicine, and.
Jiwon ParkFrom the Department of Physiology and Biophysics, College of Medicine, and.
Sang-Min KimFrom the Department of Physiology and Biophysics, College of Medicine, and.
Hyeongjin Chothe Department of Chemistry, Inha University, Incheon, Korea.
Yunkyoung LeeFrom the Department of Physiology and Biophysics, College of Medicine, and.
Inn-Oc HanFrom the Department of Physiology and Biophysics, College of Medicine, and iohan@inha.ac.kr.
Inha University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the current study was to investigate the effects of glucosamine (GlcN) on septic lethality and sepsis-induced inflammation using animal models of mice and zebrafish. GlcN pretreatment improved survival in the cecal ligation and puncture (CLP)-induced sepsis mouse model and attenuated lipopolysaccharide (LPS)-induced septic lung injury and systemic inflammation. GlcN suppressed LPS-induced M1-specific but not M2-specific gene expression. Furthermore, increased expressions of inflammatory genes in visceral tissue of LPS-injected zebrafish were suppressed by GlcN. GlcN suppressed LPS-induced activation of mitogen-activated protein kinase (MAPK) and NF-κB in lung tissue. LPS triggered a reduction in

Indexed as

AnimalsAnti-Inflammatory AgentsDisease Models, AnimalGlucosamineInflammationLung InjuryMaleMiceMice, Inbred BALB CNeutrophil InfiltrationRAW 264.7 CellsSepsisZebrafishAnti-Inflammatory AgentsGlucosamineglucose metabolisminflammationlung injuryO-GlcNAcylationsepsis

Identifiers

PMID30455348
PMCPMC6333887
OpenAlexW2901007321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.